The advantages of fentanyl for the treatment of pain: Studies of pharmacological profiles and fentanyl relatedside effects
Key word: fentanyl; antinociception; emesis; ferret.
Ahmedzai, S. and Brooks, D., 1997, Transdermal fentanyl versus sustained-release oral morphine in cancer pain: preference, efficacy, and quality of life. The TTS-Fentanyl Comparative Trial Group, J Pain Symptom Manage 13: 254-261.
Anonym, 1999, ASHP therapeutic guidelines on the pharmacologic management of nausea and vomiting in adultand pediatric patients receiving chemotheraphy or radiation theraphy or undergoing surgery, Am J Health Syst Pharm 56: 729-764.
Aparasu, R., McCoy, R.A., Weber, C., Mair, D., and Parasuraman, T.V., 1999, Opioid-induced emesis among hospitalized nonsurgical patients: effect on pain and quality of life, J Pain Symptom Manage 18: 280-288.
Barnes, N.M., Bunce, K.T., Naylor, R.J., and Rudd, J.A., 1991, The actions of fentanyl to inhibit drug-induced emesis, Neuropharmacology 30: 1073-1083.
Donner, B. and Zenz, M., 1995, Transdermal fentanyl: a new step on the therapeutic ladder, Anticancer Drugs 6: 39-43.
Donner, B., Zenz, M., Tryba, M., and Strumpf, M., 1996, Direct conversion from oral morphine to transdermal fentanyl: a multicenter study in patients with cancer pain, Pain 64: 527-534.
Fallon, M. and O'Neill B., 1997, ABC of palliative care, Constipation and diarrhoea, BMJ 315: 1293-1296.
Fallon, M.T. and Hanks, G.W., 1999, Morphine, constipation and performance status in advanced cancer patients, Palliat Med 13: 159-160.
Kamei, J., Ohsawa, M., Misawa, M., Nagase, H., and Kasuya, Y., 1995, Effect of diabetics on the morphine-induced inhibition of gastrointestinal transit, Jpn. J. Psychopharmacol 15: 165-169.
Marrow, G.R., Roscoe, J.A., and Hickok, J.T., 1998, Initial control of chemotherapy-induced nausea and vomiting in patient quality of life, Oncology 12: 32-37.
Megens, A.A., Artois, K., Vermeire, J., Meert, T., and Awouters, F.H., 1998, Comparison of the analgesic and intestinal effects of fentanyl and morphine in rats, J Pain Symptom Manage 15: 253-257.
Oettle, H., and Riess, H., 2001, Treatment of chemotherapy-induced nausea and vomiting J Cancer Res Clin Oncol 127: 340-345.
Payne, R., Mathias, S.D., Pasta, D.J., Wanke, L.A., Williams, R., and Mahmoud, R., 1998., Quality of life and cancer pain: satisfaction and side effects with transdermal fentanyl versus oral morphine, J Clin Oncol 16: 1588-1593.
Radbruch, L., Sabatowski, R., Loick, G., Kulbe, C., Kasper, M., Grond, S., and Lehmann, K.A., 2000, Constipation and the use of laxatives: a comparison between transdermal fentanyl and oral morphine, Palliat Med 14: 111-119.
Rudd, J.A., Jordan, C.C., and Naylor, R.J., 1994, Profiles of emetic action of cisplatin in the ferret: a potential model of acute and delayed emesis, Eur J Pharmacol 262: R1-2.
Tarumi, Y., 2002, Clinical implication of opioid rotation: The 23rd JNRC Proceedings Neurobiology of Opioid Receptor Symposium Abstract Book: 172-177.
Thomson, P.I., Bingham, S., Andrews, P.L.R., Patel, N., Joel, S.P., and Slevin, M.L., 1992, Morphine 6-glucoronide: a metabolite of morphine with greater emetic potency than morphine in the ferret, Br J Pharmacol 106: 3-8.
Urie, J., Fielding, H., McArthur, D., Kinnear, M., Hudson, S., and Fallon, M., 2000, Palliative care. Pharm J 265: 603-614.
- There are currently no refbacks.
Copyright (c) 2017 INDONESIAN JOURNAL OF PHARMACY
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Indonesian J Pharm indexed by:View My Stats